...
首页> 外文期刊>Life sciences >SEX-SPECIFIC EFFECTS OF GROWTH HORMONE ON HEPATIC 11-BETA-HYDROXYSTEROID DEHYDROGENASE ACTIVITY AND GENE EXPRESSION IN HYPOTHYROID RATS
【24h】

SEX-SPECIFIC EFFECTS OF GROWTH HORMONE ON HEPATIC 11-BETA-HYDROXYSTEROID DEHYDROGENASE ACTIVITY AND GENE EXPRESSION IN HYPOTHYROID RATS

机译:生长激素对大鼠甲状腺11-β-羟基甾体脱氢酶活性和基因表达的性别特异性影响

获取原文
获取原文并翻译 | 示例
           

摘要

To investigate the effects of growth hormone (GH) on 11 beta-HSD1, we determined changes in hepatic 11 beta-HSD1 activity in hypothyroid rats following treatment with subcutaneous (s.c) injection of GH for periods ranging from 24 h to 7 days. In male rats, hypothyroidism markedly reduced the hepatic 11 beta-HSD1 activity and serum testosterone levels (p < 0.01). Subcutaneous injection of GH once daily to male hypothyroid rats for 48 h inhibited hepatic 11 beta-HSD1 activity. However, the same daily dose of GH administered to male hypothyroid rats for 7 days, resulted in a marked increase in hepatic 11 beta-HSD1 activity and gene expression (p < 0.01). Furthermore, daily s.c injections of GH to castrated male hypothyroid rats for 7 days reduced hepatic 11 beta-HSD1 activity rather than inducing it, the same response seen in hypothyroid female rats. In addition, the treatment of castrated male hypothyroid rats with testosterone for 7 days significantly increased this enzyme activity (p < 0.01). The changes in hepatic II beta-HSD1 were demonstrated to be associated with the testes in hypothyroid male rats following treatment with GH for 7 days. Moreover, the prolonged exposure to GH required to induce hepatic 11 beta-HSD1 in intact hypothyroid male rats and the lack of a similar effect in castrated male hypothyroid rats suggests that this action is indirect and that it may be mediated by androgen production from Leydig cells of the testes and induced by the daily injections of GH. Treatment of hypothyroid male rats with GH at 6-h intervals, however, feminized the hepatic 11 beta-HSD1 gene expression. [References: 44]
机译:为了研究生长激素(GH)对11β-HSD1的影响,我们确定了皮下(s.c)注射GH治疗24h至7天后甲状腺功能减退大鼠肝11β-HSD1活性的变化。在雄性大鼠中,甲状腺功能减退显着降低了肝11β-HSD1活性和血清睾丸激素水平(p <0.01)。每天一次向雄性甲状腺功能减退大鼠皮下注射GH 48小时,可抑制肝11β-HSD1活性。然而,每天向雄性甲状腺功能减退的大鼠注射相同剂量的GH,连续7天,导致肝11β-HSD1活性和基因表达显着增加(p <0.01)。此外,每天向割的雄性甲状腺功能减退大鼠皮下注射GH持续7天,会降低肝脏11β-HSD1活性,而不是诱导这种活性,这与甲状腺功能减退的雌性大鼠相同。此外,用睾丸激素治疗去势雄性甲状腺功能减退的雄性大鼠7天,可显着增加这种酶的活性(p <0.01)。 GH治疗7天后,肝脏II型β-HSD1的变化与甲状腺功能减退的雄性大鼠的睾丸有关。此外,在完整的甲状腺功能减退的雄性大鼠中诱导肝11β-HSD1所需的GH长时间暴露,以及在cast割的甲状腺功能减退的雄性大鼠中缺乏类似的作用,表明该作用是间接的,并且可能是由Leydig细胞产生的雄激素介导的。睾丸的分泌,并由每天注射GH引起。间隔6小时用GH治疗甲状腺功能减退的雄性大鼠,女性肝11β-HSD1基因表达女性化。 [参考:44]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号